PIK3CA RELATED OVERGROWTH SPECTRUM
Clinical trials for PIK3CA RELATED OVERGROWTH SPECTRUM explained in plain language.
Never miss a new study
Get alerted when new PIK3CA RELATED OVERGROWTH SPECTRUM trials appear
Sign up with your email to follow new studies for PIK3CA RELATED OVERGROWTH SPECTRUM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
French hospital data reveals rare disease burden
Knowledge-focused CompletedThis study used French hospital records from 2015 to 2022 to estimate how many people have a group of rare genetic disorders called PROS. Researchers looked at over 3,600 patients to understand their age, sex, other health problems, and the costs of their care. The goal was to ge…
Matched conditions: PIK3CA RELATED OVERGROWTH SPECTRUM
Sponsor: Novartis Pharmaceuticals • Aim: Knowledge-focused
Last updated May 22, 2026 14:03 UTC
-
French registry aims to uncover the hidden prevalence of rare overgrowth diseases
Knowledge-focused CompletedThis study created the first French national registry for people with rare overgrowth syndromes caused by PIK3CA gene mutations. Researchers collected clinical and genetic information from 28 children and adults to better understand these conditions and estimate how many people a…
Matched conditions: PIK3CA RELATED OVERGROWTH SPECTRUM
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated May 22, 2026 13:54 UTC